StreetInsider.com News Articles

Form SCHEDULE 13G/A Option Care Health, Inc. Filed by: Durable Capital Partners LP

Fri, 14 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26930192.html

Form SCHEDULE 13G/A Option Care Health, Inc. Filed by: Durable Capital Partners LP

Fri, 14 Aug 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26930192.html

Deutsche Bank Downgrades Option Care Health (OPCH) to Hold

Thu, 30 Jul 2026 03:15:14 -0400

Deutsche Bank analyst Pito Chickering downgraded Option Care Health (NASDAQ: OPCH) from Buy to Hold with a price target of $24.00 (from $26.00).

The analyst comments: “OPCH posted and EBITDA beat and lowered the midpoint of their EBITDA guide by 150bps, which was good enough for the stock to react positively today. However, we believe that there could be structural concerns with OPCH’s gross profit growth algorithm in the outyears especially if the impressive HSD above market acute growth in 2026 slows. Bulls can point to the MSD-HSD GP exit rate in 2026, which combine with SG&A leverage can lead to

Deutsche Bank Downgrades Option Care Health (OPCH) to Hold

Thu, 30 Jul 2026 03:15:14 -0400

Deutsche Bank analyst Pito Chickering downgraded Option Care Health (NASDAQ: OPCH) from Buy to Hold with a price target of $24.00 (from $26.00).

Option Care Health (OPCH) Tops Q2 EPS by 2c ; Offers Guidance

Wed, 29 Jul 2026 07:58:36 -0400

Option Care Health (NASDAQ: OPCH) reported Q2 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.42 billion.

GUIDANCE:

Option Care Health sees FY2026 EPS of $1.85-$1.92, versus the consensus of $1.84. Option Care Health sees FY2026 revenue of $5.67-5.77 billion, versus the consensus of $5.71 billion.

For earnings history and earnings-related data on Option Care Health (OPCH) click here.

Option Care Health (OPCH) Tops Q2 EPS by 2c ; Offers Guidance

Wed, 29 Jul 2026 07:58:36 -0400

GUIDANCE:

Option Care Health sees FY2026 EPS of $1.85-$1.92, versus the consensus of $1.84. Option Care Health sees FY2026 revenue of $5.67-5.77 billion, versus the consensus of $5.71 billion.

For earnings history and earnings-related data on Option Care Health (OPCH) click here.

Form 10-Q Option Care Health, Inc. For: Jun 30

Wed, 29 Jul 2026 07:27:00 -0400

si-local-file:///var/storage/secattach/20260729/26830591.html

Form 10-Q Option Care Health, Inc. For: Jun 30

Wed, 29 Jul 2026 07:27:00 -0400

si-local-file:///var/storage/secattach/20260729/26830591.html

Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026

Wed, 29 Jul 2026 07:00:00 -0400

BANNOCKBURN, Ill., July 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2026.

Second Quarter 2026 Financial Highlights

(year-over-year comparisons unless otherwise noted)

Net revenue of $1,442 million, up 1.9%
GAAP net income of $53.9 million, up 6.7%
GAAP diluted earnings per share of $0.35, up 12.9%
Adjusted EBITDA of $117.5 million, up 3.0%
Adjusted diluted earnings per share of

Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026

Wed, 29 Jul 2026 07:00:00 -0400

Second Quarter 2026 Financial Highlights

(year-over-year comparisons unless otherwise noted)

Net revenue of $1,442 million, up 1.9%
GAAP net income of $53.9 million, up 6.7%
GAAP diluted earnings per share of $0.35, up 12.9%
Adjusted EBITDA of $117.5 million, up 3.0%
Adjusted diluted earnings per share of

Form 8-K Option Care Health, Inc. For: Jul 29

Wed, 29 Jul 2026 06:56:00 -0400

si-local-file:///var/storage/secattach/20260729/26830192.html

Form 8-K Option Care Health, Inc. For: Jul 29

Wed, 29 Jul 2026 06:56:00 -0400

si-local-file:///var/storage/secattach/20260729/26830192.html

Stephens Downgrades Option Care Health (OPCH) to Equal Weight

Fri, 17 Jul 2026 06:07:53 -0400

(Updated - July 17, 2026 6:07 AM EDT)

Stephens analyst Raj Kumar downgraded Option Care Health (NASDAQ: OPCH) from Overweight to Equal Weight with a price target of $24.00.

The analyst commented: "We are downgrading OPCH to EW (from OW) as we believe the relative set-up to the upside (vs. home-based care group) has become less asymmetric amid intrinsic and policy-driven dynamics. Additionally, given low N-T visibility into sustained earnings and limited catalysts to close the current valuation discount gap, we view the risk/reward as roughly balanced. While we still see OPCH as a high-quality business with attractive L- T industry exposure,

Stephens Downgrades Option Care Health (OPCH) to Equal Weight

Fri, 17 Jul 2026 06:07:53 -0400

(Updated - July 17, 2026 6:07 AM EDT)

Stephens analyst Raj Kumar downgraded Option Care Health (NASDAQ: OPCH) from Overweight to Equal Weight with a price target of $24.00.

Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call

Thu, 09 Jul 2026 16:05:00 -0400

BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2026 on Wednesday, July 29, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Conference Call Details
Participants can pre-register for the conference call at the following link: https://register-conf.media-server.com/register/BI808c970d451b4e5ba580364e7e07d20a. The call can

Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call

Thu, 09 Jul 2026 16:05:00 -0400

Form 4 Option Care Health, Inc. For: Jul 06 Filed by: Bhatia Prateek

Wed, 08 Jul 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260708/26747860.html

Form 4 Option Care Health, Inc. For: Jul 06 Filed by: Bhatia Prateek

Wed, 08 Jul 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260708/26747860.html

Form 3 Option Care Health, Inc. For: Jul 06 Filed by: Bhatia Prateek

Wed, 08 Jul 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260708/26747853.html

Form 3 Option Care Health, Inc. For: Jul 06 Filed by: Bhatia Prateek

Wed, 08 Jul 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260708/26747853.html

UBS Reiterates Buy Rating on Option Care Health (OPCH)

Tue, 16 Jun 2026 09:35:42 -0400

UBS analyst AJ Rice reiterated a Buy rating and $39.00 price target on Option Care Health (NASDAQ: OPCH).

The analyst commented, "We had a chance to catch up with OPCH today (6/15) before the quiet period. We asked OPCH for their thoughts around the potential impact from PBMs continuing to move members to their own white label STELARA biosimilar, particularly as Cigna noted to us that that 60% of its census on STELARA are now on their white label biosimilar offering. Further, CI expects to get to 100% by July 1. In response, OPCH said PBMs do not consult with them when making

Goldman Sachs Starts Option Care Health (OPCH) at Neutral

Mon, 08 Jun 2026 01:03:44 -0400

Goldman Sachs analyst Scott Fidel initiates coverage on Option Care Health (NASDAQ: OPCH) with a Neutral rating and a price target of $22.00.

The analyst comments: “We initiate research coverage of Option Care Health (OPCH) with a Neutral rating and a $22 price target, reflecting a balance between durable structural growth tailwinds in specialty infusion and the more variable near-term earnings backdrop created by therapy-specific disruption within the chronic portfolio.

Option Care Health remains a strategically well-positioned infusion platform operating inside a structurally attractive segment of healthcare services, in our view. We believe the long-term growth story supported by specialty pharmaceutical expansion

Goldman Sachs Starts Option Care Health (OPCH) at Neutral

Mon, 08 Jun 2026 01:03:44 -0400

Goldman Sachs analyst Scott Fidel initiates coverage on Option Care Health (NASDAQ: OPCH) with a Neutral rating and a price target of $22.00.

Option Care Health names Robert Okunski VP of investor relations

Thu, 04 Jun 2026 07:00:08 -0400

Option Care Health Inc. (NASDAQ: OPCH) appointed Robert Okunski as Vice President, Investor Relations, effective May 26, 2026, according to a company statement.

Okunski will lead the company's investor relations strategy and serve as the primary contact between Option Care Health and the investment community. His responsibilities include communicating the company's business strategy, financial performance, capital allocation priorities and growth opportunities to investors, analysts and stakeholders.

"Bob brings more than two decades of investor relations leadership experience across healthcare, technology and energy industries," said Meenal Sethna, Chief Financial Officer of Option Care Health.

Okunski previously served as Vice President of Investor Relations at

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

Thu, 04 Jun 2026 07:00:00 -0400

BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026.

In this role, Okunski will lead the Company’s investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company’s business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders.

“Bob